MIRA INFORM REPORT

 

 

Report Date :

28.11.2013

 

IDENTIFICATION DETAILS

 

Name :

AMOLI ORGANICS PRIVATE LIMITED

 

 

Registered Office :

322/ 4, 40 Shed Area, GIDC, Vapi – 396 195, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

19.09.1991

 

 

Com. Reg. No.:

04-016288

 

 

Capital Investment / Paid-up Capital :

Rs.46.000 Millions

 

 

CIN No.:

[Company Identification No.]

U24231GJ1991PTC016288

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

SRTA01797F

 

 

PAN No.:

[Permanent Account No.]

AACCA3990Q

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Bulk Drugs/active Pharmaceuticals Ingredients and Caters Primarily to the Anti-Inflammatory, Anti-Fungal and Anti-Depressant Segments.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (45)

 

RATING

STATUS

PROPOSED CREDIT LINE

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

Maximum Credit Limit :

USD 1100000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having a satisfactory track record. Trade relations are reported as fair. Business is active. Payments are reported to be usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES:

 

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

INDIAN ECONOMIC OVERVIEW

 

The current downturn provides an opportunity to push ahead with reforms to accelerate growth, says the latest India Development Update report released by the World Bank. The report says that the adverse effects of rupee depreciation are likely to be offset by the gains in the exports performance due to improved external competitiveness. Since May this year, the local currency has depreciated substantially and fell to a record level of Rs 68.85 to a dollar on August, 28.

 

A stagflation like situation appears to have arisen as inflation jumped to an eight month high of 6.46 % for the month of September. It is up from 6.10 % in August. Growth continues to be muted with factory output plunging to 0.6  % in August. Onion prices have risen nearly 300 % from last September. Vegetables cost nearly 90 % more than they did last year. Wake up to the economic contribution of slum dwellers. They contribute more than 7.5 % to the country’s gross domestic product, according to a recent study conducted in 50 top cities.

 

136000 estimated number of jobs created during the second quarter of the current financial year. 50000 estimated number of additional jobs in the field of corporate social responsibility in the coming years.

 

The International Finance Corporation expects to come out with its rupee linked bonds issue before the end of 2013 as a part of its plan to raise $ 1 billion. The Apple iPhone 5c (Rs 41900 for 16 GB variant) and 5s (Rs 53500 for 16GB variant) has been launched in India from 1st November.

 

The Land Acquisition Act to provide just and fair compensation to farmers will come into force from January 1 next year, said Rural Development Minister Jairam Ramesh. The Act replaces a 119 year old registration. The Securities and Exchange Board of India has approved the trading of currency futures on the Bombay Stock Exchange. The exchange plans to launch the currency futures platform with advanced trading technology by the end of November.

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

LONG TERM RATING : CRISIL BBB-

Rating Explanation

Having moderate degree of safety regarding timely servicing of financial obligation it carry moderate credit risk.

Date

31st January, 2012

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered Office/ Factory 1 :

322/ 4, 40 Shed Area, GIDC, Vapi – 396 195, Gujarat, India

Tel. No.:

91-260-22424882/ 22400383

Mobile No.:

91-9819871700 (Mr. Ramanuj Malani)

Fax No.:

91-260-22431982

E-Mail :

amoli@vsnl.com

mudoshi@amoliindia.com

rpsonica@hotmail.com

info@amoliindia.com

ramanuj@amoliindia.com

Website :

http://www.amoliindia.com

Area :

60000 sq. ft.

Location :

Leased

 

 

Corporate Office/ Factory 2 :

407, Dalamal House, Jamnadas Bajaj Road, Nariman Point, Mumbai – 40 0021, Maharashtra, India

Tel. No.:

91-22-22854715

Fax No.:

91-22-22041400 

E-Mail :

info@amoliidia.com

saleem@amoliindia.com

bhavin@amoliindia.com

kamdar@amoliindia.com

sales@amoliindia.com

govind@amoliindia.com   

 

 

Factory 3 :

Plot No. 421 to 425, 432, 433 and 436, Taluka – Padra, District: Vadodara, Gujarat, India

Tel. No.:

91-2662-3200383

 

 

DIRECTORS

 

AS ON 28.09.2012

 

Name :

Mr. Manish Umed Doshi

Designation :

Director

Address :

1201 A, Chandanbala Apartment, R.R. Thakker Road, Walkeshwar, Mumbai – 400 006, Maharashtra, India

Date of Birth/Age :

07.10.1961

Qualification :

B. Pharma

Date of Appointment :

15.10.1994

PAN No.:

AABPD3578R

DIN No.:

00210389

 

Other Directorship:

 

S. No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231MH1982PTC224236

UMEDICA LABORATORIES PRIVATE LIMITED

Director

05/01/1982

05/01/1982

Active

NO

2

U67120MH1991PTC060393

TOLSTOY INVESTMENTS PRIVATE LIMITED

Director

19/03/1991

19/03/1991

Active

NO

3

U24231GJ1991PTC016288

AMOLI ORGANICS PRIVATE LIMITED

Director

15/10/1994

15/10/1994

Active

NO

4

U99999MH1958PTC011058

URANUS ELECTRO TECHNIK PRIVATE LIMITED

Director

10/07/1995

10/07/1995

Active

NO

5

U24239MH1981PTC024656

SWETA PHARMA PRIVATE LIMITED

Director

12/08/1997

12/08/1997

Active

NO

6

U24117GJ1999PTC035456

SUJAG FINE CHEMICALS PRIVATE LIMITED

Director

19/02/1999

19/02/1999

Active

NO

7

U24239MH1989PTC051908

AGRIGUARD MANUFACTURING PRIVATE LIMITED

Director

27/12/1999

27/12/1999

Active

NO

8

U24231GJ1988PTC010742

BROMOFINE CHEM PRIVATE LIMITED

Director

26/12/2000

26/12/2000

Active

NO

9

U72900MH2004PTC144104

AMOLI INFOTECH PRIVATE LIMITED

Director

20/01/2004

20/01/2004

Active

NO

10

U51909MH2003PTC142648

KMI BUSINESS TECHNOLOGIES PRIVATE LIMITED

Director

17/08/2004

17/08/2004

Active

NO

11

L45200PN1991PLC129428

KOLTE-PATIL DEVELOPERS LIMITED

Director

04/07/2007

26/12/2006

Active

NO

12

U67110MH2009PTC191826

AMOLI INVESTMENT SERVICES PRIVATE LIMITED

Director

18/04/2009

18/04/2009

Active

NO

13

U70102MH2009PTC191879

AMOLI PROPERTIES PRIVATE LIMITED

Director

21/04/2009

21/04/2009

Active

NO

14

U67100MH2009PTC192008

UMEDICA INVESTMENT SERVICES PRIVATE LIMITED

Director

24/04/2009

24/04/2009

Active

NO

15

U70102MH2009PTC192006

UMEDICA PROPERTIES PRIVATE LIMITED

Director

24/04/2009

24/04/2009

Active

NO

16

U85199PN2005PTC020895

STEMONE BIOLOGICALS PRIVATE LIMITED

Director

26/06/2010

26/06/2010

Active

NO

 

 

Name :

Mrs. Vandana Manish Doshi

Designation :

Director

Address :

1201 A, Chandanbala Apartment, R.R. Thakker Road, Walkeshwar, Mumbai – 400 006, Maharashtra, India

Date of Birth/Age :

23.08.1962

Date of Appointment :

19.01.1991

PAN No.:

AAEPD2835J

DIN No.:

00211618

 

Other Directorship:

 

S. No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24239MH1981PTC024656

SWETA PHARMA PRIVATE LIMITED

Director

20/03/1985

20/03/1985

Active

NO

2

U67120MH1991PTC060393

TOLSTOY INVESTMENTS PRIVATE LIMITED

Director

19/03/1991

19/03/1991

Active

NO

3

U24231GJ1991PTC016288

AMOLI ORGANICS PRIVATE LIMITED

Director

19/09/1991

19/09/1991

Active

NO

4

U99999MH1978PTC020156

URANUS ELECTRONICS PRIVATE LIMITED

Director

07/03/1996

07/03/1996

Active

NO

5

U72900MH2004PTC144104

AMOLI INFOTECH PRIVATE LIMITED

Director

20/01/2004

20/01/2004

Active

NO

6

U67190MH2005PTC155528

APE-AAN FINSER PRIVATE LIMITED

Director

22/08/2005

22/08/2005

Active

NO

7

U67110MH2009PTC191826

AMOLI INVESTMENT SERVICES PRIVATE LIMITED

Director

18/04/2009

18/04/2009

Active

NO

8

U70102MH2009PTC191879

AMOLI PROPERTIES PRIVATE LIMITED

Director

21/04/2009

21/04/2009

Active

NO

9

U67100MH2009PTC192008

UMEDICA INVESTMENT SERVICES PRIVATE LIMITED

Director

24/04/2009

24/04/2009

Active

NO

10

U70102MH2009PTC192006

UMEDICA PROPERTIES PRIVATE LIMITED

Director

24/04/2009

24/04/2009

Active

NO

 

 

Name :

Mr. Rupesh Suryakant Kamdar 

Designation :

Director

Address :

Flat No.603, Somnath CHS, Neelkanth Valley, 7th Floor, Rajawadi, Ghatkopar (East), Mumbai - 400 077, Maharashtra, India

Date of Birth/Age :

11.04.1971

Date of Appointment :

26.09.2009

PAN No.:

AFVPK9124K

DIN No.:

02358348

 

Other Directorship:

 

S. No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231GJ1991PTC016288

AMOLI ORGANICS PRIVATE LIMITED

Director

26/09/2009

11/11/2008

Active

NO

 

Name :

Mr. Kundan Lal Khurana 

Designation :

Director

Address :

103, Sector 35A, Chandigarh – 160 035, India

Date of Birth/Age :

22.09.1942

Date of Appointment :

26.09.2009

DIN No.:

02193237

 

Other Directorship:

 

S. No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U67120CH2000PTC023953

COMPACT ENGINEERING SOLUTIONS PRIVATE LIMITED

Director

03/12/2003

03/12/2003

23/02/2010

Active

NO

2

U24110MH1997PTC106915

GLADE ORGANICS PRIVATE LIMITED

Director

02/08/2006

02/08/2006

-

Active

NO

3

U01403CH2008PTC031301

SATYAM REFRIGERATION AND ENGINEERING COMPANY PRIVATE LIMITED

Director

08/07/2008

08/07/2008

-

Strike off

NO

4

U24231GJ1991PTC016288

AMOLI ORGANICS PRIVATE LIMITED

Director

26/09/2009

11/11/2008

-

Active

NO

5

L27100AP1989PLC010122

ZENOTECH LABORATORIES LIMITED

Director

25/07/2012

25/07/2012

-

Active

NO

 

Name :

Mr. Mukundray Harshadray Bhatt 

Designation :

Director

Address :

Ananya, Tithal Road, Valsad – 396 001, Gujarat, India

Date of Birth/Age :

28.09.1951

Date of Appointment :

26.09.2009

DIN No.:

02200427

 

Other Directorship:

 

S. No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24210MH1992PTC066957

R3 CROP CARE PRIVATE LIMITED

Director

01/04/2009

27/05/1992

Active

NO

2

U24110GJ1999PLC035663

ATRO LIMITED

Director

26/03/1999

26/03/1999

Active

NO

3

U24231GJ1991PTC016288

AMOLI ORGANICS PRIVATE LIMITED

Director

26/09/2009

11/11/2008

Active

NO

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 28.09.2012

 

Names of Shareholders

 

No. of Shares

Vandna M. Doshi

1631776

Manish U. Doshi

1070496

Indu U. Doshi

78880

Manish U. Doshi (HUF)

498848

Tolstoy Investments Private Limited, India

320000

Port Limited, Mauritius

1000000

TOTAL

4600000

 

AS ON 28.09.2012

 

Equity Share Breakup

Percentage of Holding

Category

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

21.74

Bodies corporate

6.96

Directors or relatives of directors

71.30

TOTAL

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Bulk Drugs/active Pharmaceuticals Ingredients and Caters Primarily to the Anti-Inflammatory, Anti-Fungal and Anti-Depressant Segments.

 

 

Products :

Bulk Drugs

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

v      State Bank of India,

Industrial Finance Branch, The Arcade, World Trade Centre, Cuffe Parade, Mumbai – 400 005, Maharashtra, India

 

v      EXIM Bank,

World Trade Centre, Cuffe Parade, Mumbai – 400 005, Maharashtra, India

 

v      ICICI Bank Limited,

215, Free Press House, Free Press Journal Marg, Nariman Point, Mumbai – 400 021, Maharashtra, India

 

v      ICICI Bank Limited,

Land Mark Race Cource Circle, Alkapuri, Baroda – 390 015, Gujarat, India

 

 

Facilities :

Secured Loan

Rs. In Millions

31.03.2012

Rs. In Millions

31.03.2011

Long Term Borrowings

 

 

Loans and Advances From Directors

170.900

134.800

Loans taken for vehicles

0.663

0.413

Short Term Borrowings

 

 

Working Capital Loans from Banks

297.348

224.334

 

 

 

TOTAL

468.911

359.547

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Contractor Nayak and Kishnadwala

Chartered Accountants

Address :

Jash Chambers, 7, Sir. P. M. Road, Mumbai, Maharashtra, India

Tel No.:

91-22-66359681/82/83 / 66230 600 / 22661819

PAN No.:

AACFC8587E

 

 

Associates :

v      Umedica Laboratories Limited

Address: 403, Dalamal House, J. B. Road, Nariman Point, Mumbai - 400 021, Maharashtra, India

Tel. No.: 91-22-285 4715

Fax No.: 91-22-204 1400

E-Mail: umedica@vsnl.com

Website:  http://www.amoliindia.com

-It is engaged in manufacturing and exporting of a wide range of Injectables, Tablets, Capsules, Suspensions and Dry Syrups, etc.

-Subject is Government Recognised Export House.

 

v      Sweta Pharma Private Limited

v      KMI Business Technologies Private Limited

v      Tolstory Investment Private Limited

v      Bromofine Chem Private Limited

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2012

 

Authorised Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

12500000

Equity Share

Rs.10/- each

Rs. 125.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

4600000

Equity Share

Rs.10/- each

Rs. 46.000 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

46.000

46.000

(b) Reserves & Surplus

 

251.903

235.554

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

297.903

281.554

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

171.563

135.213

(b) Deferred tax liabilities (Net)

 

11.618

19.830

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

10.384

9.798

Total Non-current Liabilities (3)

 

193.565

164.841

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

333.976

234.787

(b) Trade payables

 

526.579

393.335

(c) Other current liabilities

 

74.433

76.928

(d) Short-term provisions

 

1.811

0.956

Total Current Liabilities (4)

 

936.799

706.006

 

 

 

 

TOTAL

 

1428.267

1152.401

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

406.107

354.518

(ii) Intangible Assets

 

0.000

0.000

(iii) Capital work-in-progress

 

9.687

0.220

(b) Non-current Investments

 

1.117

1.117

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

25.308

20.670

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

442.219

376.525

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

289.916

270.935

(c) Trade receivables

 

533.926

378.920

(d) Cash and cash equivalents

 

24.057

20.403

(e) Short-term loans and advances

 

35.331

30.887

(f) Other current assets

 

102.818

74.731

Total Current Assets

 

986.048

775.876

 

 

 

 

TOTAL

 

1428.267

1152.401

 

 

SOURCES OF FUNDS

 

 

 

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

46.000

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

232.375

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

278.375

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

288.031

2] Unsecured Loans

 

 

160.363

TOTAL BORROWING

 

 

448.394

DEFERRED TAX LIABILITIES

 

 

21.850

 

 

 

 

TOTAL

 

 

748.619

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

360.475

Capital work-in-progress

 

 

6.773

 

 

 

 

INVESTMENT

 

 

1.117

DEFERREX TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

 

212.321

 

Sundry Debtors

 

 

374.075

 

Cash & Bank Balances

 

 

8.276

 

Other Current Assets

 

 

0.000

 

Loans & Advances

 

 

91.768

Total Current Assets

 

 

686.440

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

 

 

266.347

 

Other Current Liabilities

 

 

29.755

 

Provisions

 

 

10.084

Total Current Liabilities

 

 

306.186

Net Current Assets

 

 

380.254

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

748.619

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Net Sales

1722.730

1363.900

1227.505

 

 

Other Income

 

 

46.332

 

 

TOTAL                                     (A)

1722.730

1363.900

1273.837

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Material Consumed

NA

NA

759.389

 

 

Manufacturing Expenses

 

 

198.435

 

 

Personal Cost

 

 

117.504

 

 

Administration & Selling Expenses

 

 

84.126

 

 

Increase/Decrease in Stock

 

 

(35.185)

 

 

Prior Period Income/ Expenses

 

 

0.000

 

 

TOTAL                                     (B)

NA

NA

1124.269

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

NA

NA

149.568

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

NA

NA

39.770

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

54.220

58.950

109.798

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

NA

NA

56.720

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX (E-F)                  (G)

NA

NA

53.078

 

 

 

 

 

Less

TAX                                                                  (H)

NA

NA

15.080

 

 

 

 

 

 

PROFIT/ (LOSS) AFTER TAX (G-H)                   (I)

16.350

3.180

37.998

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

185.070

181.890

143.890

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

201.420

185.070

181.888

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export of goods (FOB)

NA

NA

383.846

 

TOTAL EARNINGS

NA

NA

383.846

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

NA

NA

444.698

 

 

Capital Goods

NA

NA

0.927

 

TOTAL IMPORTS

NA

NA

445.625

 

 

 

 

 

 

Earnings Per Share (Rs.)

3.55

0.69

8.26

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

0.95
0.23
2.98

 

 

 
 
 

Net Profit Margin

(PBT/Sales)

(%)

NA
NA
4.32

 

 

 
 
 

Return on Total Assets

(PBT/Total Assets}

(%)

NA
NA
5.07

 

 

 
 
 

Return on Investment (ROI)

(PBT/Networth)

 

NA
NA
0.19

 

 

 
 
 

Debt Equity Ratio

(Total Debt/Networth)

 

1.70
1.31
1.61

 

 

 
 
 

Current Ratio

(Current Asset/Current Liability)

 

1.05
1.10
2.24

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

DETAILS OF UNSECURED LOAN

 

PARTICULARS

Rs. In Millions

31.03.2012

Rs. In Millions

31.03.2011

Short Term Borrowings

 

 

Loans Repayable on Demand from Others

36.628

10.453

 

 

 

TOTAL

36.628

10.453

 

INDEX OF CHARGES

 

S. No

Charge ID

Date of Charge Creation /Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN

1

10449164

06/09/2013

50,000,000.00

DBS BANK LIMITED

221, Fort House, 3rd Floor, D. N. Road, Fort, Mumbai, Maharashtra - 400001, India

B85054567

2

10354320

21/11/2012 *

126,000,000.00

ICICI BANK LIMITED

Landmarkrace Cource Circle, Alkapuri, Baroda, Gujarat - 390015, India

B62572813

3

10027182

15/09/2006

140,000,000.00

ICICI BANK LIMITED

Landmarkrace Cource Circle, Alkapuri, Baroda, Gujarat - 390015, India

A05726054

4

90105486

21/11/2012 *

210,600,000.00

ICICI BANK LIMITED

Landmarkrace Cource Circle, Alkapuri, Baroda, Gujarat - 390015, India

B63335202

5

90106321

10/09/2013 *

326,200,000.00

STATE BANK OF INDIA

Industrial Finance Branch, World Trade Centre, Cuffe Parade, Mumbai, Maharashtra - 400005, India

B85340842

* Date of charge modification

 

 

 

OPERATIONS

 

Despite the recessionary trends prevailing in global and in domestic economy, the Company has achieved higher sales and other income of Rs.1722.730 Millions for the F.Y.2011-12, reflecting a growth of 26.31 % over the previous year. Export sales have grown from Rs. 564.420 Millions to Rs.739.450 Millions i.e. by 31.01% over the previous year. The net profit for the year has inclined substantially to Rs.16.350 Millions, from Rs.3.180 Millions in the previous year.

 

 

FIXED ASSETS

 

v      Factory Plot

v      Starr Quarter Plot

v      Factory Building

v      Plant and machinery

v      Electrical Equipments

v      Motorcar and Vehicles

v      Motorcar

v      Motor Lorry

v      Furniture Fixture and Office equipments

v      Computer

v      Efferent Treatment Plant

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 62.36

UK Pound

1

Rs. 62.36

Euro

1

Rs. 84.68

 

 

INFORMATION DETAILS

 

Report Prepared by :

KVT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

 

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.